Background and Purpose-Sex differences have been recognized in stroke risk; however, the sex-dependent genetic contribution to stroke is unclear. We sought to examine the sex-dependent associations between genes involved in lipid metabolism and carotid atherosclerotic plaque, a subclinical precursor of stroke. Methods-For the Genetic Determinant of Subclinical Carotid Disease study, 287 Dominicans ascertained through the Northern Manhattan Study were examined for carotid plaque using high-resolution ultrasound. Sixty-four single nucleotide polymorphisms (SNPs) in 11 lipid-related genes were genotyped. Plaque presence and plaque subphenotypes, including multiple, thick, irregular, and calcified plaque, were analyzed. First, the interaction between each SNP and sex was evaluated for association with each plaque phenotype using multiple logistic regression and controlling for age, smoking, and the main effects of sex and SNP. For SNPs with suggestive evidence for interaction with sex (PϽ0.1 for the interaction term), stratification analysis by sex was performed to evaluate the sex-specific association between the SNP and plaque phenotypes. Results-The most compelling finding is with the missense SNP rs11053646 (K167N) in the OLR1 gene, which encodes lectin-like oxidized low-density lipoprotein receptor. Stratification analysis revealed a strong association between rs11053646 and all plaque phenotypes in women (OR, 2.44 to 5.86; Pϭ0.0003 to 0.0081) but not in men (OR, 0.85 to 1.22; Pϭ0.77 to 0.92). Key Words: candidate genes Ⅲ carotid plaque Ⅲ lipids Ⅲ OLR1 Ⅲ sex S ex-dependent differences have been reported in the outcomes and incidence of stroke. [1] [2] [3] [4] The variation in lifestyle factors between the sexes does not fully explain these differences, suggesting sex-dependent genetic risk factors may play a role in stroke burden. 5 A recent meta-analysis showed that women are 50% more likely to have a maternal than a paternal history of stroke, whereas no similar excess exists in men. 4 Given the etiologic heterogeneity of stroke, it may be more advantageous to examine subclinical phenotypes. Carotid atherosclerotic plaque is an important subclinical precursor of stroke and other vascular diseases. 6 Substantial heritability of subclinical carotid atherosclerosis has been reported by us and others. 7, 8 A sex difference in carotid plaque area has been reported with women having less plaque area than men at all ages. 9 An important step in the pathogenesis of atherosclerosis involves the uptake of lipoproteins into the arterial wall. 10,11 Therefore, genetic variation in lipid-related genes may influence metabolism of lipoproteins and affect atherogenesis. Numerous studies have examined associations between carotid atherosclerosis and polymorphisms in lipidrelated genes with few exploring the sex-specific genetic effects. [12] [13] [14] The aim of this study was to examine sex-specific associations between single nucleotide polymorphisms (SNPs) in genes involved in lipid metabolism and carotid plaque phenotypes among individuals of Dominican Republic descent.
S ex-dependent differences have been reported in the outcomes and incidence of stroke. [1] [2] [3] [4] The variation in lifestyle factors between the sexes does not fully explain these differences, suggesting sex-dependent genetic risk factors may play a role in stroke burden. 5 A recent meta-analysis showed that women are 50% more likely to have a maternal than a paternal history of stroke, whereas no similar excess exists in men. 4 Given the etiologic heterogeneity of stroke, it may be more advantageous to examine subclinical phenotypes. Carotid atherosclerotic plaque is an important subclinical precursor of stroke and other vascular diseases. 6 Substantial heritability of subclinical carotid atherosclerosis has been reported by us and others. 7, 8 A sex difference in carotid plaque area has been reported with women having less plaque area than men at all ages. 9 An important step in the pathogenesis of atherosclerosis involves the uptake of lipoproteins into the arterial wall. 10, 11 Therefore, genetic variation in lipid-related genes may influence metabolism of lipoproteins and affect atherogenesis. Numerous studies have examined associations between carotid atherosclerosis and polymorphisms in lipidrelated genes with few exploring the sex-specific genetic effects. [12] [13] [14] The aim of this study was to examine sex-specific associations between single nucleotide polymorphisms (SNPs) in genes involved in lipid metabolism and carotid plaque phenotypes among individuals of Dominican Republic descent.
Methods

Study Population
The 287 Dominican Hispanic participants in the Genetic Determinants of Subclinical Carotid Disease substudy were drawn from the Northern Manhattan Study cohort, which has been described before. 15 Subjects were included in the substudy if they had carotid ultrasound performed and a blood sample collected. Vascular risk factors collected included body mass index, hypertension, diabetes, dyslipidemia, and smoking history. Hypertension was defined by history, systolic blood pressure Ն140 mm Hg, or diastolic blood pressure Ն90 mm Hg. Diabetes was defined by history or fasting blood sugar Ն126 mg/dL. Smoking was defined as "ever" versus "never." Fasting blood samples were analyzed for high-and lowdensity lipoprotein cholesterol, total cholesterol, and triglycerides.
Carotid Ultrasonography
High resolution B-mode carotid ultrasound was performed according to a standard scanning and reading protocol by a certified sonologist as described before. 6, 13 Both internal and common carotid arteries as well as the bifurcations were examined for the presence of atherosclerotic plaque, defined as an area of focal wall thickening Ͼ50% greater than the surrounding wall. Maximal carotid plaque thickness was measured at the highest plaque prominence in any of the 3 carotid artery segments. Acoustic shadowing was defined as a reduction in amplitude of echoes caused by intervening structures with high attenuation. Calcified plaque is defined as plaque with acoustic shadowing. Plaque surface characteristics (regular or irregular) were recorded. Intra-and interrater agreement for plaque calcification and surface characteristics were Ͼ0.90 in our laboratory. 16 The primary phenotype of interest was presence of any plaque, and secondary phenotypes were (1) maximal carotid plaque thickness Ͼ1.9 mm (thick plaque); (2) Ͼ1 plaque in the carotid arteries (multiple plaque); (3) irregular plaque; and (4) calcified plaque. Each of these phenotypes was compared with patients without plaque as the control group.
Gene and SNP Selection
Based on a literature review, we selected 11 lipid metabolism genes that have been implicated in atherosclerosis. These genes included apolipoprotein B, microsomal triglyceride transfer protein, lipoprotein lipase, cholesterol 7-␣-hydroxylase, apolipoprotein A-V, oxidized low-density lipoprotein receptor 1 (OLR1), hepatic triglyceride lipase, endothelial cell-derived lipase, hormone-sensitive lipase, apolipoprotein E, and phospholipid transfer protein. Sixty-four tagging or functional SNPs in these genes were selected. SNP genotyping was performed using the GoldenGate Assay (Illumina Inc) by Illumina. All SNPs showed no significant deviation from Hardy-Weinberg equilibrium (PϾ0.0001).
Statistical Analysis
In the first stage of the analysis, assuming an additive genetic model, we used multiple logistic regression to look for evidence for interaction between sex and each SNP in association with plaque phenotypes at the same time as taking into account the main effects of the SNP, sex, age, and smoking (SAS 9.0). A significant probability value for the interaction term would suggest that there was a sex-dependent difference in the association between the SNP and plaque phenotype. No adjustment was made for hypertension, diabetes, and body mass index because of a lack of significant correlations with the plaque phenotypes (PϾ0.1) in univariate models. Dyslipidemia was not included as a covariate because the SNPs might contribute to the plaque risk through serum lipid level.
In the second stage, a stratified analysis was done for SNPs having a suggestive interaction with sex (PϽ0.1 for the interaction term). Separately in each sex stratum, multiple logistic regression was used to examine the association between each SNP and corresponding plaque phenotype at the same time as controlling for age and smoking. Sex-specific ORs and CIs for SNP association were estimated in each sex stratum.
Results
Baseline clinical characteristics of the study subjects are illustrated in Table 1 . The mean age of the participants was 64Ϯ7 years. Women had a slightly lower prevalence of plaque than men (43.1% versus 51.7%, Pϭ0.15). In comparison to men, women smoked less (PϽ0.0001) and had greater body mass index (Pϭ0.0003), total cholesterol (PϽ0.0001), low-density lipoprotein (Pϭ0.004), and high-density lipoprotein (PϽ0.0001). There were no significant differences between men and women in prevalence of hypertension, diabetes mellitus, and age (Table 1) .
We first looked for evidence for interactions between sex and SNPs in association with the primary (plaque presence) and secondary (multiple, thick, irregular, and calcified) carotid plaque phenotypes. This analysis revealed that 12 SNPs in 7 genes (microsomal triglyceride transfer protein, OLR1, phospholipid transfer protein, apolipoprotein B, hepatic triglyceride lipase, apolipoprotein E, lipoprotein lipase) had suggestive evidence (PϽ0.1 for the interaction term) for interaction with sex in at least 1 of the plaque phenotypes (Supplemental Table I ; available at http://stroke.ahajournals.org). The missense OLR1 SNP rs11053646 (K167N), located on chromosome 12p13, showed the most consistent interaction with sex in association with all plaque phenotypes: presence (Pϭ0.067), multiple (Pϭ0.077), thick (Pϭ0.094), irregular (Pϭ0.074), and calcified (Pϭ0.077).
An interaction between a SNP and sex in the first stage of analysis suggested a sex-specific association between the SNP and plaque phenotype. In the second stage of analysis, the 12 SNPs with suggestive evidence for interaction with sex were further analyzed in women and men separately. Among the 12 SNPs, 5 SNPs had interaction with sex in association with multiple phenotypes (1 SNP with all 5 phenotypes, 2 SNPs with 3 phenotypes, and 2 SNPs with 2 phenotypes), and 7 SNPs had an interaction with sex in association with only 1 phenotype. In total, 22 association tests were performed in each stratum for a total of 44 association tests (Supplemental Table II ). This analysis revealed that OLR1/rs11053646 displayed the strongest difference between women and men: the C allele of rs11053646 was significantly associated with all plaque phenotype in women: presence (Pϭ0.0051; OR, 2.44), multiple (Pϭ0.0062; OR, 3.03), thick (Pϭ0.0053; OR, 3.39), irregular (Pϭ0.0003; OR, 5.86), and calcified (Pϭ0.0081; OR, 5.57). The association between rs11053646 and irregular plaque remained significant even after the Bonferroni correction for multiple testing (significance cutoff of 0.05/44ϭ0.0011). The association between the OLR1 SNP and plaque phenotypes was attenuated in men (Pϭ0.77 to 0.92; OR, 0.85 to 1.22; Table 2 ).
Because smoking is more prevalent in men than in women (Table 1) , we further tested if the sex-dependent association between rs11053646 and plaque phenotypes was driven by smoking status. First, we evaluated the SNP-smoking interaction in a similar model as we did for the SNP-sex interaction. This analysis did not support a strong interaction between the SNP and smoking history (Pϭ0.15 for the interaction term). Second, we evaluated the SNP main effect in ever and never smoking strata for rs11053646. Marginal evidence for association (Pϭ0.02 for plaque presence) was found in nonsmokers (Nϭ138) and no evidence for an association (Pϭ0.45 for plaque presence) was found in smokers (Nϭ149). Given that the majority of nonsmokers were women, the marginal evidence for an association in nonsmokers was most likely due to the strong effect of rs11053646 in women.
Discussion
We have provided statistical evidence that the K167N polymorphism in OLR1 has sex-specific effects on carotid plaque burden in people of Dominican-Hispanic origin. Sex has long been recognized as a strong modifier of cardiovascular disease risk. Our findings provide a plausible genetic basis for the sex differences in vascular disease risk.
OLR1 encodes the lectin-like oxidized low-density lipoprotein receptor (LOX-1), which is mainly expressed in vascular endothelial cells but also is present in macrophages, platelets, and smooth muscle cells. 17 Oxidized low-density lipoprotein is a well-documented proatherogenic molecule. As the main receptor for oxidized low-density lipoprotein in endothelial cells, LOX-1 binds, internalizes, and degrades oxidized low-density lipoprotein. This process activates a cascade of events leading to endothelial dysfunction, the initial stage of atherogenesis. 18, 19 Atherosclerosis mouse models demonstrated that OLR1 deletion reduced, whereas OLR1 overexpression increased, plaque formation and development. 20, 21 The rs11053646 polymorphism causes an amino acid change from lysine to asparagine in the oxidized low-density lipoprotein binding domain of LOX-1. Functional analysis has demonstrated that the substitution of lysine by asparagine at position 167 reduces oxidized low-density lipoprotein binding and uptake in vitro. This nonsynonymous change also alters the oxidized low-density lipoprotein-induced LOX-1 †MAF indicates minor allele frequency in cases. The minor allele is C in our studied population; the MAF in controls is 0.11 and 0.2 for women and men, respectively. The P value that remained significant (Bonferroni-corrected P value of 0.05) after adjusting for multiple testing is in bold.
expression. 22 We found that the minor allele of rs11053646, encoding asparagine, was specifically associated with carotid plaque in women but not in men. Several studies have examined this functional SNP and risk for cardiovascular diseases, including myocardial infarction, ischemic stroke, and stenosis. [23] [24] [25] [26] [27] [28] [29] [30] However, the results have been inconsistent. Different phenotypes and human populations studied in each study could be responsible for the inconsistent associations. It is worthwhile to point out that some of those studies did not match sex between cases and control subjects, and some of those studies were mainly composed of male subjects. Therefore, the sex-specific effect reported in our study could also contribute to the inconsistency between studies.
We examined 5 phenotypes of carotid plaque. It is not clear whether these carotid plaque phenotypes each represent a distinct phenotype and different risk to clinical manifestation. Several studies have suggested that certain carotid plaque phenotypes such as irregular plaque represent vulnerable plaque susceptible to thrombotic events. 31 Interestingly, the strongest association was found for irregular plaque (OR, 5.9; Pϭ0.0003 in women) to rs11053646, suggesting this variant could have important implications in identifying patients, especially women, who are at risk for adverse cardiovascular events. It is not clear how this missense variation, residing on an autosomal chromosome, confers sex-dependent effects on carotid plaque. The amino acid change in LOX-1 might have a distinct effect in the presence of different levels of sex hormones and hormone receptors. 32 Alternatively, differences in other vascular risk factors between men and women could interact with the genetic variation and contribute to the sex-specific genetic effect. Exploring the gene-environment interactions in a future study might help to illustrate the biological basis for the sex-specific effects.
One of the limitations of our study is the small sample size, particularly in the secondary phenotype analysis. Replication in an independent data set is desired for the intriguing finding at OLR1/rs11053646. A major concern with small sample size is false-negative results. We cannot exclude the possibility of a sex-specific association with other SNPs/genes that did not meet the significance threshold in our study. Another limitation of our study is that a relatively small number of candidate genes were examined. Further study is needed to expand our study to test other lipid-related genes as well as validate the findings in our study.
Nonetheless, our study contributes to the literature suggesting the importance of sex differences in the genetic basis of atherosclerosis. A deeper understanding of these sex-specific genetic effects will improve identification of individuals at risk for atherosclerosis and new pharmaceutical targets. This knowledge will help to design novel prevention as well as treatment strategies of stroke and other vascular diseases. 
